| Předmět: |
|
| Zdroj: |
Biomedical Market Newsletter; 6/30/2011, p229-230, 2p |
| Abstrakt: |
The article reports on Tetraphase Pharmaceuticals Inc.'s presentation at the 2011 BIO International Convention held from June 27-30, 2011 in Washington D. C. It states that Tetraphase's president and chief executive officer (CEO) Guy Macdonald will participate in a panel entitled "Financing Beyond the Lead Compound: Attracting Funding for Multiproduct Platforms" on June 28. It notes that the company uses its synthetic chemistry technology platform in tetracycline antibiotics development. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
